SCHULMAN AMY W

CIK 000143822614 companiesINDIANAPOLIS, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001438226

Recent Transactions

50 trades

Purchase
Camp4 Therapeutics Corp$CAMP
Common Stock
2025-09-11$1.53/sh+85,468→ 197,661 total
Purchase
Camp4 Therapeutics Corp$CAMP
Common Stock
2025-09-11$1.53/sh+1,221,721→ 2,825,500 total
Award
FRACTYL HEALTH, INC.$GUTS
Stock Option
2025-06-11+22,500→ 22,500 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-08+775→ 11,961 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-05-08+1,558→ 1,558 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-03-13$131.21/sh+2,750→ 11,186 total
Purchase
FRACTYL HEALTH, INC.$GUTS
Common Stock
2025-03-13$1.17/sh+8,550→ 8,550 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-03-13−2,750→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series B Preferred Stock
2024-10-15−3,967,234→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series B Preferred Stock
2024-10-15−3,967,234→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series A Prime Preferred Stock
2024-10-15−14,020,475→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+353,718→ 1,603,779 total
Purchase
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15$11.00/sh+909,090→ 909,090 total
Purchase
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15$11.00/sh+909,090→ 909,090 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series A Prime Preferred Stock
2024-10-15−980,829→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+1,250,061→ 1,250,061 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series A Prime Preferred Stock
2024-10-15−14,020,475→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series A Prime Preferred Stock
2024-10-15−980,829→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+24,745→ 112,193 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+87,448→ 87,448 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series B Preferred Stock
2024-10-15−277,536→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+353,718→ 1,603,779 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+1,250,061→ 1,250,061 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series B Preferred Stock
2024-10-15−277,536→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+87,448→ 87,448 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+24,745→ 112,193 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-25$131.21/sh+8,500→ 16,936 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-06-25−8,500→ 2,750 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-06-25$240.00/sh−8,500→ 8,436 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-05-29$66.83/sh+30,000→ 30,136 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-05-29$148.93/sh−11,516→ 8,499 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-05-29$149.76/sh−63→ 8,436 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-05-29−30,000→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-05-29$148.21/sh−10,121→ 20,015 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-05-16+5,228→ 5,228 total
Award
FRACTYL HEALTH, INC.$GUTS
Stock Option
2024-02-01+45,000→ 45,000 total
Award
SQZ Biotechnologies Co
Stock Option
2023-06-14+39,875→ 39,875 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-05-18+3,454→ 3,454 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2023-02-23−136→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-23+136→ 136 total
Award
SQZ Biotechnologies Co
Stock Option
2022-06-15+20,000→ 20,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2022-05-18+5,153→ 5,153 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2022-02-23+136→ 136 total
Exercise/Conversion
SQZ Biotechnologies Co
Stock Option
2021-12-22−7,458→ 3,072 total
Exercise/Conversion
SQZ Biotechnologies Co
Common Stock
2021-12-22$2.02/sh+10,091→ 200,775 total
Exercise/Conversion
SQZ Biotechnologies Co
Stock Option
2021-12-22−10,091→ 439 total
Exercise/Conversion
SQZ Biotechnologies Co
Stock Option
2021-12-22−6,581→ 3,949 total
Exercise/Conversion
SQZ Biotechnologies Co
Common Stock
2021-12-22$4.59/sh+7,458→ 208,233 total
Exercise/Conversion
SQZ Biotechnologies Co
Common Stock
2021-12-22$4.59/sh+6,581→ 214,814 total
Purchase
SQZ Biotechnologies Co
Common Stock
2021-12-13$10.94/sh+1,850→ 1,850 total

SCHULMAN AMY W

Recent Transactions

Companies

Recent Filings

Address